{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T14:09:06Z","timestamp":1772374146796,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T00:00:00Z","timestamp":1666656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["552429"],"award-info":[{"award-number":["552429"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["552429"],"award-info":[{"award-number":["552429"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["552429"],"award-info":[{"award-number":["552429"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["552429"],"award-info":[{"award-number":["552429"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Organ transplant recipients (OTRs) are at greater risk of basal cell carcinomas (BCCs) than non-OTRs, but histopathologic differences between BCCs in OTRs and the general population are largely unknown. We compared clinicopathologic features of BCCs in OTRs vs the general population in Queensland, Australia. Details of BCC tumors (site, size, level of invasion, subtype, biopsy procedure) were collected from histopathology reports in two prospective skin cancer studies, one in OTRs and one general-population-based. We used log-binomial regression models to estimate age- and sex-adjusted prevalence ratios (PR) with 95% confidence intervals (CIs) for BCC features. Overall, there were 702 BCCs in 200 OTRs and 1725 BCCs in 804 population cases. Of these, 327 tumors in 128 OTRs were higher risk BCCs (any head and neck BCC;\u2009\u2265\u20092\u00a0cm on trunk\/extremities), more per person than 703 higher risk BCCs in 457 cases in the general population (chi-square <jats:italic>p<\/jats:italic>\u2009=\u20090.008). Among head\/neck BCCs, OTRs were more likely than general population cases to have BCCs on scalp\/ear than on face\/lip\/neck (PR\u2009=\u20091.5, 95%CI 1.2\u20131.8). Although aggressive subtypes were less common among higher risk BCCs in OTRs, BCCs invading beyond the dermis were almost twice as prevalent in OTRs (PR\u2009=\u20091.8, 95% CI 1.3\u20132.6) than the general population.<\/jats:p>","DOI":"10.1007\/s00403-022-02403-6","type":"journal-article","created":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T18:02:56Z","timestamp":1666720976000},"page":"771-777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Basal cell carcinomas in organ transplant recipients versus the general population: clinicopathologic study"],"prefix":"10.1007","volume":"315","author":[{"given":"Nirmala","family":"Pandeya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9677-8885","authenticated-orcid":false,"given":"Zainab","family":"Jiyad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8846-1930","authenticated-orcid":false,"given":"Elsemieke I.","family":"Plasmeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3444-1907","authenticated-orcid":false,"given":"Mandy","family":"Way","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9566-7179","authenticated-orcid":false,"given":"Nicole","family":"Isbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1338-2151","authenticated-orcid":false,"given":"Scott","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9553-5870","authenticated-orcid":false,"given":"Daniel C.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3261-9345","authenticated-orcid":false,"given":"Peter","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4770-561X","authenticated-orcid":false,"given":"H. Peter","family":"Soyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2563-9559","authenticated-orcid":false,"given":"David C.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2753-4841","authenticated-orcid":false,"given":"Adele C.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,25]]},"reference":[{"issue":"17","key":"2403_CR1","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1056\/NEJMra022137","volume":"348","author":"S Euvrard","year":"2003","unstructured":"Euvrard S, Kanitakis J, Claudy A (2003) Skin cancers after organ transplantation. N Engl J Med 348(17):1681\u20131691. https:\/\/doi.org\/10.1056\/NEJMra022137","journal-title":"N Engl J Med"},{"issue":"3","key":"2403_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1001\/jamadermatol.2016.4920","volume":"153","author":"GL Garrett","year":"2017","unstructured":"Garrett GL, Blanc PD, Boscardin J et al (2017) Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol 153(3):296\u2013303. https:\/\/doi.org\/10.1001\/jamadermatol.2016.4920","journal-title":"JAMA Dermatol"},{"issue":"1","key":"2403_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/jamadermatol.2018.4406","volume":"155","author":"J Lanz","year":"2019","unstructured":"Lanz J, Bouwes Bavinck JN, Westhuis M et al (2019) Aggressive squamous cell carcinoma in organ transplant recipients. JAMA Dermatol 155(1):66\u201371. https:\/\/doi.org\/10.1001\/jamadermatol.2018.4406","journal-title":"JAMA Dermatol"},{"key":"2403_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/bjd.18812","volume":"183","author":"M Way","year":"2020","unstructured":"Way M, Marquart L, Chambers DC et al (2020) Skin cancer multiplicity in lung transplant recipients: prospective, population-based study. Br J Dermatol 183:503\u2013508. https:\/\/doi.org\/10.1111\/bjd.18812","journal-title":"Br J Dermatol"},{"issue":"4 Pt 2","key":"2403_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1524-4725.2004.30147.x","volume":"30","author":"C Ulrich","year":"2004","unstructured":"Ulrich C, Schmook T, Sachse MM et al (2004) Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 30(4 Pt 2):622\u2013627. https:\/\/doi.org\/10.1111\/j.1524-4725.2004.30147.x","journal-title":"Dermatol Surg"},{"issue":"10","key":"2403_CR6","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1111\/ajt.14382","volume":"17","author":"A Mittal","year":"2017","unstructured":"Mittal A, Colegio OR (2017) Skin cancers in organ transplant recipients. Am J Transplant 17(10):2509\u20132530. https:\/\/doi.org\/10.1111\/ajt.14382","journal-title":"Am J Transplant"},{"issue":"1","key":"2403_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/bjd.14260","volume":"174","author":"S-Y Li","year":"2016","unstructured":"Li S-Y, Quereshi AA, Li W-L (2016) Basal cell carcinoma in organ transplant recipients. Br J Dermatol 174(1):15\u201316. https:\/\/doi.org\/10.1111\/bjd.14260","journal-title":"Br J Dermatol"},{"issue":"6","key":"2403_CR8","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1046\/j.1523-1747.1998.00217.x","volume":"110","author":"MT Bastiaens","year":"1998","unstructured":"Bastiaens MT, Hoefnagel JJ, Bruijn JA et al (1998) Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 110(6):880\u2013884. https:\/\/doi.org\/10.1046\/j.1523-1747.1998.00217.x","journal-title":"J Invest Dermatol"},{"issue":"9","key":"2403_CR9","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/archderm.139.9.1133","volume":"139","author":"J Kanitakis","year":"2003","unstructured":"Kanitakis J, Alhaj-Ibrahim L, Euvrard S, Claudy A (2003) Basal cell carcinomas developing in organ transplant recipients. Clinicopathologic study of 176 cases. Arch Dermatol 139(9):1133\u20131137. https:\/\/doi.org\/10.1001\/archderm.139.9.1133","journal-title":"Arch Dermatol"},{"issue":"2","key":"2403_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jaad.2005.10.049","volume":"54","author":"CA Harwood","year":"2006","unstructured":"Harwood CA, Proby CM, McGregor JM, Sheaff MT et al (2006) Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 54(2):290\u2013300. https:\/\/doi.org\/10.1016\/j.jaad.2005.10.049","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2403_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/bjd.14153","volume":"174","author":"B Krynitz","year":"2016","unstructured":"Krynitz B, Olsson H, Lundh Rozell B, Lindel\u00f6f B, Edgren G, Smedby KE (2016) Risk of basal cell carcinoma in Swedish organ transplant recipients: a population-based study. Br J Dermatol 174(1):95\u2013103. https:\/\/doi.org\/10.1111\/bjd.14153","journal-title":"Br J Dermatol"},{"issue":"7","key":"2403_CR12","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.jid.2016.02.804","volume":"136","author":"MR Iannacone","year":"2016","unstructured":"Iannacone MR, Sinnya S, Pandeya N et al (2016) Prevalence of skin cancer and actinic skin tumors in high-risk kidney and liver transplant recipients in Queensland, Australia. J Invest Dermatol 136(7):1382\u20131386. https:\/\/doi.org\/10.1016\/j.jid.2016.02.804","journal-title":"J Invest Dermatol"},{"issue":"4","key":"2403_CR13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/ije\/dys107","volume":"41","author":"CM Olsen","year":"2012","unstructured":"Olsen CM, Green AC, Neale RE et al (2012) Cohort profile: the QSkin sun and health study. Int J Epidemiol 41(4):929\u2013929i. https:\/\/doi.org\/10.1093\/ije\/dys107","journal-title":"Int J Epidemiol"},{"key":"2403_CR14","series-title":"IARC","first-page":"26","volume-title":"WHO classification of skin tumours. World Health Organization classification of tumours","author":"J Messini","year":"2018","unstructured":"Messini J, Epstein EH, Kossard S et al (2018) Basal cell carcinoma. In: Elder DE, Massi D, Scolyer RA, Willemze R (eds) WHO classification of skin tumours. World Health Organization classification of tumours, vol 11, 4th edn. IARC. Lyon, France, pp 26\u201334","edition":"4"},{"key":"2403_CR15","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.jaad.2021.01.052","volume":"85","author":"FC Morgan","year":"2021","unstructured":"Morgan FC, Ruiz ES, Karia PS et al (2021) Brigham and Women\u2019s Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death. J Am Acad Dermatol 85:582\u2013587. https:\/\/doi.org\/10.1016\/j.jaad.2021.01.052","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"2403_CR16","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1001\/jamainternmed.2021.2643","volume":"181","author":"E Linos","year":"2021","unstructured":"Linos E, Chren MM (2021) Active surveillance as a management option for low-risk basal cell carcinoma. JAMA Intern Med 181(8):1032\u20131033. https:\/\/doi.org\/10.1001\/jamainternmed.2021.2643","journal-title":"JAMA Intern Med"},{"key":"2403_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejca.2019.06.003","volume":"118","author":"K Peris","year":"2019","unstructured":"Peris K, Fargnoli MC, Garbe C et al (2019) Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines. Eur J Cancer 118:10\u201334. https:\/\/doi.org\/10.1016\/j.ejca.2019.06.003","journal-title":"Eur J Cancer"},{"issue":"Suppl 2","key":"2403_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2133.2012.11083.x","volume":"167","author":"SC Flohil","year":"2012","unstructured":"Flohil SC, Proby CM, Forrest AD et al (2012) Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions. Br J Dermatol 167(Suppl 2):22\u201328. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11083.x","journal-title":"Br J Dermatol"},{"issue":"10","key":"2403_CR19","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2340\/00015555-3234","volume":"99","author":"EI Plasmeijer","year":"2019","unstructured":"Plasmeijer EI, Jiyad Z, Way M et al (2019) Extreme incidence of skin cancer in kidney and liver transplant recipients living with high sun exposure. Acta Derm Venereol 99(10):929\u2013930. https:\/\/doi.org\/10.2340\/00015555-3234","journal-title":"Acta Derm Venereol"},{"key":"2403_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jamadermatol.2021.2582","volume":"157","author":"SDB Smith","year":"2021","unstructured":"Smith SDB, Reimann JDR, Horn TD (2021) Communication between dermatologists and dermatopathologists via the pathology requisition: opportunities to improve patient care. JAMA Dermatol 157:1033\u20131034. https:\/\/doi.org\/10.1001\/jamadermatol.2021.2582","journal-title":"JAMA Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-022-02403-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-022-02403-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T11:03:23Z","timestamp":1681124603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-022-02403-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,25]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["2403"],"URL":"https:\/\/doi.org\/10.1007\/s00403-022-02403-6","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,25]]},"assertion":[{"value":"6 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"HPS is a shareholder of MoleMap NZ Limited and e-derm consult GmbH, and undertakes regular teledermatological reporting for both companies. HPS is a Medical Consultant for Canfield Scientific Inc, MoleMap Australia Pty Ltd, Blaze Bioscience Inc, Revenio Research Oy and a Medical Advisor for First Derm. All other authors state no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Provided.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}